Skip to main content
. 2017 May 24;8(30):50305–50313. doi: 10.18632/oncotarget.18148

Table 2. Progression of the patient's illness and the therapeutic regimen.

Time Patient history and treatment regimen
Feb, 2015 Headache, vomiting, and mild left hemiparesis. The patient was diagnosed with glioblastoma and underwent gross total resection.
March/April, 2015 Standard radiation and concomitant temozolomide chemotherapy.
May, 2015-Sept, 2015 Adjuvant temozolomide 5 cycles (150mg/day in first cycle, 200mg/day in other cycle)
Sept, 2015 The relapse of the GBM
Oct, 2015 Next generation sequencing demonstrates EGFR mutation
Oct, 2015 Perform a PET/CT by EGFR antibody-18-FDG shows non-uniform EGFR positive reaction
Nov, 2015 Oral administration of erlotinib 150 mg/day
Nov, 2015-Feb, 2016 SD (less edema and reduced compression of the lateral ventricles)
March, 2016 Recurrence of GBM
May,2016 Patient death

GBM: Glioblastoma multiforme SD: Stable Disease